Methotrexate Tablet
Product Images NDC 0378-0014

2 FDA label images from Mylan Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 0378-0014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image 01

Image 01
Chemical structure of methotrexate, depicting its molecular arrangement with rings, amino groups, and carboxyl groups characteristic of the compound.*
FDA Label Image

Image 02

Image 02
Label for Methotrexate 2.5 mg oral tablets by Mylan Pharmaceuticals Inc., containing 100 tablets. The label includes the NDC 0378-0014-01, usage instructions for storage and handling, and warnings to keep out of reach of children and protect from light. It notes the product is a cytotoxic agent and dispensed with patient information leaflet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.